Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:740603.
doi: 10.1155/2012/740603. Epub 2012 Dec 25.

A case of hypogonadotropic hypogonadism caused by opioid treatment for nonmalignant chronic pain

Yukiko Tabuchi  1 , Tetsuyuki Yasuda, Hideaki Kaneto, Tetsuhiro Kitamura, Junji Kozawa, Michio Otsuki, Akihisa Imagawa, Aya Nakae, Youichi Matsuda, Hironobu Uematsu, Takashi Mashimo, Masahiko Shibata, Iichiro Shimomura
Affiliations

A case of hypogonadotropic hypogonadism caused by opioid treatment for nonmalignant chronic pain

Yukiko Tabuchi et al. Case Rep Med. 2012.

Abstract

We report a case of 42-year-old male patient with hypogonadotropic hypogonadism. He suffered from general fatigue and erectile dysfunction after the treatment with transdermal fentanyl for chronic pain by traffic injury. Endocrine examinations and hormone stimulating tests showed that he had hypogonadotropic hypogonadism. Brain magnetic resonance imaging (MRI) showed no abnormal findings, and he had no past history of accounting for acquired hypogonadotropic hypogonadism. Therefore, his hypogonadism was diagnosed to be caused by opioid treatment. Although opioid-induced endocrine dysfunctions are not widely recognized, this case suggests that we should consider the possibility of endocrine dysfunctions in patients with opioid treatment.

PubMed Disclaimer

References

    1. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. Journal of Pain and Symptom Management. 2004;28(2):176–188. - PubMed
    1. Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. Journal of Clinical Endocrinology and Metabolism. 2000;85(6):2215–2222. - PubMed
    1. Roberts LJ, Finch PM, Pullan PT, Bhagat CI, Price LM. Sex hormone suppression by intrathecal opioids: a prospective study. Clinical Journal of Pain. 2002;18(3):144–148. - PubMed
    1. Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. Journal of Pain. 2002;3(5):377–384. - PubMed
    1. Daniell HW, Lentz R, Mazer NA. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. Journal of Pain. 2006;7(3):200–210. - PubMed

LinkOut - more resources